Alvera Podiatry Group is categorized under Podiatrists in Encinitas, CA and active since 2002.
Alvera Podiatry Group was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact Adam Dustin, Owner at the company’s single location by writing to 317 North El Camino Real # 501, Encinitas, California CA 92024 or by phoning (760) 436-5533. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alvera Podiatry Group |
| Contact Person: | Adam Dustin, Owner |
| Address: | 317 North El Camino Real # 501, Encinitas, California 92024 |
| Phone Number: | (760) 436-5533 |
| Website Address: | alverapodiatry.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Podiatrists |
| SIC Code: | 8043 |
| NAICS Code: | 6213910 |
| Share This Business: |
Alvera Podiatry Group was started in 2002 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Adam Dustin, Owner for inquiries that concern Alvera Podiatry Group by calling the company number (760) 436-5533, as your correspondence is most welcome. Additionally, the physical location of the single location of Alvera Podiatry Group can be found at the coordinates 33.052204,-117.2609 as well as the street address 317 North El Camino Real # 501 in Encinitas, California 92024.
For its online presence, you may visit Alvera Podiatry Group’s website at alverapodiatry.com and engage with its social media outlets through on Twitter and on Facebook.